The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight ...

FFF Enterprises, Inc., recognized as the nation’s most trusted specialty drug distributor and diversified healthcare company, ...

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as a breakthrough against a disease that takes ...

There are several successful investing strategies in the stock market and one of them is Dogs of the Dow. It is a strategy ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Coartem Baby, which was cleared by health authorities in Switzerland, will fill an important gap in treatment. Novartis plans ...

Shares of Eton Pharmaceuticals rose sharply in premarket trading Tuesday after the pharmaceutical company said the Food and Drug Administration has accepted its application seeking approval of its ...

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...